VALIDATION OF THE I.T50 METHOD FOR ASSESSING NEURONAL RESPONSIVENESS TO MICROIONTOPHORETIC APPLICATIONS - A SINGLE-CELL RECORDING STUDY

被引：12
作者：
BRUNEL, S [1 ]
DEMONTIGNY, C [1 ]
机构：
[1] UNIV MONTREAL, FAC MED, NEUROSCI RES CTR, MONTREAL H3C 3J7, QUEBEC, CANADA
来源：
JOURNAL OF PHARMACOLOGICAL METHODS | 1988年 / 19卷 / 01期
关键词：
D O I：
10.1016/0160-5402(88)90041-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：23 / 30
页数：8
相关论文
共 29 条
[1]   EFFECTS OF THE 2 ANTIDEPRESSANT DRUGS MIANSERIN AND INDALPINE ON THE SEROTONERGIC SYSTEM - SINGLE-CELL STUDIES IN THE RAT [J].
BLIER, P ;
DEMONTIGNY, C ;
TARDIF, D .
PSYCHOPHARMACOLOGY, 1984, 84 (02) :242-249
[2]   EFFECTS OF QUIPAZINE ON PRE-SYNAPTIC AND POSTSYNAPTIC SEROTONIN RECEPTORS - SINGLE CELL STUDIES IN THE RAT CNS [J].
BLIER, P ;
DEMONTIGNY, C .
NEUROPHARMACOLOGY, 1983, 22 (04) :495-499
[3]   MEASUREMENT OF DOSE IN MICROELECTROPHORESIS EXPERIMENTS [J].
BRADSHAW, CM ;
SZABADI, E .
NEUROPHARMACOLOGY, 1974, 13 (06) :407-415
[4]   DIURNAL RHYTHMS IN THE RESPONSIVENESS OF HIPPOCAMPAL PYRAMIDAL NEURONS TO SEROTONIN, NOREPINEPHRINE, GAMMA-AMINOBUTYRIC-ACID AND ACETYLCHOLINE [J].
BRUNEL, S ;
DEMONTIGNY, C .
BRAIN RESEARCH BULLETIN, 1987, 18 (02) :205-212
[5]   MICROIONTOPHORETIC RELEASE OF DRUGS FROM MICROPIPETS - USE OF NA-24 AS A MODEL [J].
CLARKE, G ;
HILL, RG ;
SIMMONDS, MA .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 48 (01) :156-161
[6]   CENTRAL SYNAPTIC TRANSMISSION - MICROELECTROPHORETIC STUDIES [J].
CURTIS, DR ;
CRAWFORD, JM .
ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 :209-+
[7]  
DEMONTIGNY C, 1984, J PHARMACOL EXP THER, V228, P230
[8]   PREFERENTIAL ACTION OF 5-METHOXYTRYPTAMINE AND 5-METHOXYDIMETHYLTRYPTAMINE ON PRESYNAPTIC SEROTONIN RECEPTORS - COMPARATIVE IONTOPHORETIC STUDY WITH LSD AND SEROTONIN [J].
DEMONTIGNY, C ;
AGHAJANIAN, GK .
NEUROPHARMACOLOGY, 1977, 16 (12) :811-818
[9]   FAILURE OF CHRONIC LITHIUM TREATMENT TO BLOCK TRICYCLIC ANTIDEPRESSANT-INDUCED 5-HT SUPER-SENSITIVITY [J].
GALLAGER, DW ;
BUNNEY, WE .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 307 (02) :129-133
[10]  
GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI
123